152 related articles for article (PubMed ID: 7919350)
1. Structural requirements of platelet chemokines for neutrophil activation.
Yan Z; Zhang J; Holt JC; Stewart GJ; Niewiarowski S; Poncz M
Blood; 1994 Oct; 84(7):2329-39. PubMed ID: 7919350
[TBL] [Abstract][Full Text] [Related]
2. Chemokine regulation of human megakaryocytopoiesis.
Gewirtz AM; Zhang J; Ratajczak J; Ratajczak M; Park KS; Li C; Yan Z; Poncz M
Blood; 1995 Oct; 86(7):2559-67. PubMed ID: 7670101
[TBL] [Abstract][Full Text] [Related]
3. Activation of human basophils through the IL-8 receptor.
Krieger M; Brunner T; Bischoff SC; von Tscharner V; Walz A; Moser B; Baggiolini M; Dahinden CA
J Immunol; 1992 Oct; 149(8):2662-7. PubMed ID: 1383321
[TBL] [Abstract][Full Text] [Related]
4. Diverging signal transduction pathways activated by interleukin-8 and related chemokines in human neutrophils: interleukin-8, but not NAP-2 or GRO alpha, stimulates phospholipase D activity.
L'Heureux GP; Bourgoin S; Jean N; McColl SR; Naccache PH
Blood; 1995 Jan; 85(2):522-31. PubMed ID: 7812007
[TBL] [Abstract][Full Text] [Related]
5. Platelet factor 4 binds to interleukin 8 receptors and activates neutrophils when its N terminus is modified with Glu-Leu-Arg.
Clark-Lewis I; Dewald B; Geiser T; Moser B; Baggiolini M
Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3574-7. PubMed ID: 8475106
[TBL] [Abstract][Full Text] [Related]
6. Functional and ligand binding specificity of the rabbit neutrophil IL-8 receptor.
Thomas KM; Taylor L; Prado G; Romero J; Moser B; Car B; Walz A; Baggiolini M; Navarro J
J Immunol; 1994 Mar; 152(5):2496-500. PubMed ID: 8133060
[TBL] [Abstract][Full Text] [Related]
7. The CXC chemokines growth-regulated oncogene (GRO) alpha, GRObeta, GROgamma, neutrophil-activating peptide-2, and epithelial cell-derived neutrophil-activating peptide-78 are potent agonists for the type B, but not the type A, human interleukin-8 receptor.
Ahuja SK; Murphy PM
J Biol Chem; 1996 Aug; 271(34):20545-50. PubMed ID: 8702798
[TBL] [Abstract][Full Text] [Related]
8. Presence of autoantibodies to interleukin-8 or neutrophil-activating peptide-2 in patients with heparin-associated thrombocytopenia.
Amiral J; Marfaing-Koka A; Wolf M; Alessi MC; Tardy B; Boyer-Neumann C; Vissac AM; Fressinaud E; Poncz M; Meyer D
Blood; 1996 Jul; 88(2):410-6. PubMed ID: 8695787
[TBL] [Abstract][Full Text] [Related]
9. Effects of the neutrophil-activating peptide NAP-2, platelet basic protein, connective tissue-activating peptide III and platelet factor 4 on human neutrophils.
Walz A; Dewald B; von Tscharner V; Baggiolini M
J Exp Med; 1989 Nov; 170(5):1745-50. PubMed ID: 2681518
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of neutrophil functions by the ELR(+) CXC chemokine platelet basic protein.
Ehlert JE; Ludwig A; Grimm TA; Lindner B; Flad HD; Brandt E
Blood; 2000 Nov; 96(9):2965-72. PubMed ID: 11049972
[TBL] [Abstract][Full Text] [Related]
11. CXC chemokines bind to unique sets of selectivity determinants that can function independently and are broadly distributed on multiple domains of human interleukin-8 receptor B. Determinants of high affinity binding and receptor activation are distinct.
Ahuja SK; Lee JC; Murphy PM
J Biol Chem; 1996 Jan; 271(1):225-32. PubMed ID: 8550564
[TBL] [Abstract][Full Text] [Related]
12. Defining an antigenic epitope on platelet factor 4 associated with heparin-induced thrombocytopenia.
Ziporen L; Li ZQ; Park KS; Sabnekar P; Liu WY; Arepally G; Shoenfeld Y; Kieber-Emmons T; Cines DB; Poncz M
Blood; 1998 Nov; 92(9):3250-9. PubMed ID: 9787161
[TBL] [Abstract][Full Text] [Related]
13. High- and low-affinity binding of GRO alpha and neutrophil-activating peptide 2 to interleukin 8 receptors on human neutrophils.
Schumacher C; Clark-Lewis I; Baggiolini M; Moser B
Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10542-6. PubMed ID: 1438244
[TBL] [Abstract][Full Text] [Related]
14. The N terminus of interleukin-8 (IL-8) receptor confers high affinity binding to human IL-8.
Suzuki H; Prado GN; Wilkinson N; Navarro J
J Biol Chem; 1994 Jul; 269(28):18263-6. PubMed ID: 7518426
[TBL] [Abstract][Full Text] [Related]
15. The amino-terminal residues in the crystal structure of connective tissue activating peptide-III (des10) block the ELR chemotactic sequence.
Malkowski MG; Lazar JB; Johnson PH; Edwards BF
J Mol Biol; 1997 Feb; 266(2):367-80. PubMed ID: 9047370
[TBL] [Abstract][Full Text] [Related]
16. High activity suppression of myeloid progenitor proliferation by chimeric mutants of interleukin 8 and platelet factor 4.
Daly TJ; LaRosa GJ; Dolich S; Maione TE; Cooper S; Broxmeyer HE
J Biol Chem; 1995 Oct; 270(40):23282-92. PubMed ID: 7559482
[TBL] [Abstract][Full Text] [Related]
17. A natural motif approach to protein design: a synthetic leucine zipper peptide mimics the biological function of the platelet factor 4 protein.
Butcher DJ; Kowalska MA; Li S; Luo Z; Shan S; Lu Z; Niewiarowski S; Huang Z
FEBS Lett; 1997 Jun; 409(2):183-7. PubMed ID: 9202142
[TBL] [Abstract][Full Text] [Related]
18. Granulocyte chemotactic protein 2 acts via both IL-8 receptors, CXCR1 and CXCR2.
Wolf M; Delgado MB; Jones SA; Dewald B; Clark-Lewis I; Baggiolini M
Eur J Immunol; 1998 Jan; 28(1):164-70. PubMed ID: 9485196
[TBL] [Abstract][Full Text] [Related]
19. The CXC-chemokine neutrophil-activating peptide-2 induces two distinct optima of neutrophil chemotaxis by differential interaction with interleukin-8 receptors CXCR-1 and CXCR-2.
Ludwig A; Petersen F; Zahn S; Götze O; Schröder JM; Flad HD; Brandt E
Blood; 1997 Dec; 90(11):4588-97. PubMed ID: 9373270
[TBL] [Abstract][Full Text] [Related]
20. Evidence for a granule targeting sequence within platelet factor 4.
El Golli N; Issertial O; Rosa JP; Briquet-Laugier V
J Biol Chem; 2005 Aug; 280(34):30329-35. PubMed ID: 15964840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
